Immunohistochemistry staining results revealed a correlation among PRMT7, FAK Y397 and cortactin Y421 phosphorylation levels, and the clinical aggressiveness of breast cancer (Figure 8E,F and Figure 8—figure supplement 1). The gene discussed is PTK2; the disease is breast cancer.